Press Releases :: Nighthawk Biosciences, Inc. (NHWK)

Aug 13, 2020 7:00am EDT

Heat Biologic's COVID-19 Vaccine Demonstrates Robust T Cell Driven Immune Response to SARS-CoV-2 in Preclinical Studies

Aug 07, 2020 7:00am EDT

Heat Biologics Provides Second Quarter 2020 Business Update

Aug 05, 2020 7:30am EDT

Heat Biologics Highlights Importance of T cell Immunity to Prevent COVID-19

Jul 29, 2020 7:30am EDT

Heat Biologics COVID-19 Vaccine Demonstrates Immunogenicity Proof-of-Concept in Pre-Clinical Studies

Jul 27, 2020 6:30am EDT

Heat Biologics Regains Compliance with Nasdaq Minimum Bid Price Rule

Jun 22, 2020 7:30am EDT

Heat Biologics Announces First Patient Treated in First-in-Human Clinical Trial of PTX-35

Jun 18, 2020 7:30am EDT

Heat Biologics Announces Initiation of the Lead Clinical Trial Site for PTX-35

Jun 08, 2020 7:30am EDT

Heat Biologics Announces FDA Clearance of Investigational New Drug (IND) Application for PTX-35

Jun 04, 2020 7:30am EDT

Heat Biologics Provides Update on COVID-19 Vaccine Efforts

May 29, 2020 8:00am EDT

Heat Biologics Presents Positive Survival Benefit for HS-110 in Combination with Nivolumab in Phase 2 Lung Cancer Trial at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

rss_feed News RSS

OUR ECOSYSTEM